Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

598 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Epidermal growth factor receptor modulates the tumorigenic potential of melanoma.
Diaz A, Suarez E, Blanco R, Lopez A, Montero E. Diaz A, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14:159-66. doi: 10.2741/3237. Front Biosci (Landmark Ed). 2009. PMID: 19273060
Functional expression of human-epidermal-growth-factor receptor in a melanoma cell line.
Diaz A, Suarez E, Blanco R, Badia T, Rivero D, Lopez-Requena A, Lopez A, Montero E. Diaz A, et al. Biotechnol Appl Biochem. 2007 Sep;48(Pt 1):21-7. doi: 10.1042/BA20070009. Biotechnol Appl Biochem. 2007. PMID: 17472582
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial.
Caballero I, Aira LE, Lavastida A, Popa X, Rivero J, González J, Mesa M, González N, Coba K, Lorenzo-Luaces P, Wilkinson B, Santiesteban Y, Santiesteban Y, Troche M, Suarez E, Crombet T, Sánchez B, Casacó A, Macías A, Mazorra Z. Caballero I, et al. Front Pharmacol. 2017 May 10;8:263. doi: 10.3389/fphar.2017.00263. eCollection 2017. Front Pharmacol. 2017. PMID: 28539888 Free PMC article.
Characterization of the antibody response against NeuGcGM3 ganglioside elicited in non-small cell lung cancer patients immunized with an anti-idiotype antibody.
Hernández AM, Toledo D, Martínez D, Griñán T, Brito V, Macías A, Alfonso S, Rondón T, Suárez E, Vázquez AM, Pérez R. Hernández AM, et al. J Immunol. 2008 Nov 1;181(9):6625-34. doi: 10.4049/jimmunol.181.9.6625. J Immunol. 2008. PMID: 18941253
1E10 anti-idiotype vaccine in non-small cell lung cancer: experience in stage IIIb/IV patients.
Alfonso S, Diaz RM, de la Torre A, Santiesteban E, Aguirre F, Pérez K, Rodríguez JL, Barroso Mdel C, Hernández AM, Toledo D, Gabri MR, Alonso DF, Viada C, Gómez RE, Suárez E, Vazquez AM, Perez R, Macias AE. Alfonso S, et al. Cancer Biol Ther. 2007 Dec;6(12):1847-52. doi: 10.4161/cbt.6.12.5000. Epub 2007 Sep 8. Cancer Biol Ther. 2007. PMID: 18075301 Clinical Trial.
Functionally fused antibodies--a novel adjuvant fusion system.
Larsen M, Jensen KB, Christensen PA, Suarez E, Paris D, Sanz L, Ravn P, Sauce D, Saas P, Goletz S, Alvarez-Vallina L, Kristensen P. Larsen M, et al. J Immunol Methods. 2008 Dec 31;339(2):220-7. doi: 10.1016/j.jim.2008.09.015. Epub 2008 Oct 12. J Immunol Methods. 2008. PMID: 18854189
Antibodies capable of recognizing key molecular targets isolated e.g. by phage display technology have been used in the pursuit of new and improved therapies for prevalent human diseases. ...
Antibodies capable of recognizing key molecular targets isolated e.g. by phage display technology have been used in the pursuit of ne …
Rearrangement of only one human IGHV gene is sufficient to generate a wide repertoire of antigen specific antibody responses in transgenic mice.
Suárez E, Magadán S, Sanjuán I, Valladares M, Molina A, Gambón F, Díaz-Espada F, González-Fernández A. Suárez E, et al. Mol Immunol. 2006 Apr;43(11):1827-35. doi: 10.1016/j.molimm.2005.10.015. Epub 2005 Dec 15. Mol Immunol. 2006. PMID: 16343622
Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I.
Cuesta AM, Suárez E, Larsen M, Jensen KB, Sanz L, Compte M, Kristensen P, Alvarez-Vallina L. Cuesta AM, et al. Immunology. 2006 Apr;117(4):502-6. doi: 10.1111/j.1365-2567.2006.02325.x. Immunology. 2006. PMID: 16556264 Free PMC article.
Establishment of an immortalized PARP-1-/- murine endothelial cell line: a new tool to study PARP-1 mediated endothelial cell dysfunction.
Carrillo A, Monreal Y, Ramirez P, Suarez E, Parrilla P, Menissier-de Murcia J, de Murcia G, Alvarez-Vallina L, Yélamos J. Carrillo A, et al. J Cell Biochem. 2005 Apr 15;94(6):1163-74. doi: 10.1002/jcb.20385. J Cell Biochem. 2005. PMID: 15696577
After TNF-alpha treatment, HYKO6 cells exhibited increased expression of E-selectin and VCAM-1. Likewise, NF-kappaB-dependent transcriptional activation was increased in the HYKO6 cell line in response to TNF-alpha at a level similar to that found for primary PARP-1-/- cel …
After TNF-alpha treatment, HYKO6 cells exhibited increased expression of E-selectin and VCAM-1. Likewise, NF-kappaB-dependent transcr …
598 results
Jump to page
Feedback